It has been found that the knockdown of CD226‐stimulating molecules to inhibit macrophage M1 polarization reduces systemic inflammation, thereby reducing obesity (Ma et al. 2021). Here, CD226 is linked to obesity due to melanocortin 4 receptor deficiency.